REG - Cambridge Nutrition. - Appointment of Operations Director

Cambridge Nutritional SciencesAnnouncement

29/01/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240129:nRSc1059Ba&default-theme=true

RNS Number : 1059B  Cambridge Nutritional Sciences PLC  29 January 2024

Cambridge Nutritional Sciences plc

(the 'Company' or 'CNS')

 

Appointment of Operations Director

 

Senior leader from Chartwell Consulting with track record of improving
efficiency and productivity joins CNS

 

Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical
diagnostics company focused on promoting a personalised and functional
approach to health and nutrition, announces the appointment of James Cooper
as Operations Director.

 

James joins from Chartwell Consulting where, since 2014, he was responsible
for leading step change operational improvements across a wide range of
manufacturing industries. During his nine-year tenure his responsibilities
included working with industry leading executive teams to deliver financial
benefits through sustained operational improvements, as well as designing and
implementing multi-phase project plans to hit operational targets and
successfully delivering large-scale complex projects. Most recently James
helped to increase the productivity of a large QC lab within a pharmaceutical
company and boost the output capacity of a medical biomaterial company. James
has a demonstrable track record in leading large teams and bringing together
multiple departments to drive towards shared goals. He also has an MSci in
Materials Science, and a BA Hons in Natural Sciences from Cambridge
University.

 

James Cooper, Operations Director, Cambridge Nutritional Sciences, said:

"I am excited to join CNS as the inaugural Operations Director at this pivotal
time in the Company's journey. I have a track record of delivering operational
improvements and productivity across a wide range of industries spanning
pharmaceutical, packaging, industrial products and food. I thrive on
understanding how things work and solving complex problems and embrace the
challenge of working with diverse teams to help make fundamental long term
business improvements."

 

Commenting on James' appointment, Jag Grewal, Chief Executive Officer, said:

"We are delighted James has joined CNS to lead the permanent continuous
improvement function in our operations department, created to promote further
efficiencies and productivity across the business. James' insight, experience
and expertise will be invaluable in spearheading this division, helping to
enable and expedite CNS's next phase of growth."

 

Contacts:

 

 Cambridge Nutritional Sciences plc                              www.cnsplc.com (http://www.cnsplc.com)
 Jag Grewal, Chief Executive Officer       via Walbrook PR

 Cavendish Capital Markets Limited                             Tel: 020 7220 0500
 Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
 Nigel Birks / Harriet Ward (ECM)

 Walbrook PR Limited  Tel: 020 7933 8780 or CNS@walbrookpr.com (mailto:CNS@walbrookpr.com)
 Paul McManus / Charlotte Edgar                                Mob: 07980 541 893 / 07884 664 686
 Sam Allen                                                     Mob: 07502 558 258

 

 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical
diagnostics company focused on industry-leading Health and Nutrition products.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAZZGZMDVLGDZM